Gossamer Assets Non Current from 2010 to 2024
| GOSS Stock | USD 0.71 0.03 4.28% |
Check Gossamer Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Gossamer main balance sheet or income statement drivers, such as Interest Income of 1.5 M, Interest Expense of 8.2 M or Selling General Administrative of 36.5 K, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.33. Gossamer financial statements analysis is a perfect complement when working with Gossamer Bio Valuation or Volatility modules.
Gossamer | Assets Non Current |
About Gossamer Bio Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Gossamer Bio income statement, its balance sheet, and the statement of cash flows. Gossamer Bio investors use historical funamental indicators, such as Gossamer Bio's Assets Non Current, to determine how well the company is positioned to perform in the future. Although Gossamer Bio investors may use each financial statement separately, they are all related. The changes in Gossamer Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Gossamer Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Gossamer Bio Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Gossamer Bio. Please read more on our technical analysis and fundamental analysis pages.
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California. Gossamer Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 185 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Gossamer Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Gossamer Bio's short interest history, or implied volatility extrapolated from Gossamer Bio options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Gossamer Bio Correlation against competitors. For more information on how to buy Gossamer Stock please use our How to Invest in Gossamer Bio guide.You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Complementary Tools for Gossamer Stock analysis
When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stocks Directory Find actively traded stocks across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |
Is Gossamer Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gossamer Bio. If investors know Gossamer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gossamer Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.18) | Return On Assets (0.37) | Return On Equity (4.80) |
The market value of Gossamer Bio is measured differently than its book value, which is the value of Gossamer that is recorded on the company's balance sheet. Investors also form their own opinion of Gossamer Bio's value that differs from its market value or its book value, called intrinsic value, which is Gossamer Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gossamer Bio's market value can be influenced by many factors that don't directly affect Gossamer Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gossamer Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Gossamer Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gossamer Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.